blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2922526

EP2922526 - MANUFACTURING OF SEMI-PLASTIC PHARMACEUTICAL DOSAGE UNITS [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  24.09.2021
Database last updated on 15.07.2024
FormerGrant of patent is intended
Status updated on  01.06.2021
FormerExamination is in progress
Status updated on  10.02.2017
Most recent event   Tooltip29.04.2024New entry: Date of oral proceedings 
Applicant(s)For all designated states
Intervet International B.V.
Wim de Körverstraat 35
5831 AN Boxmeer / NL
[2015/40]
Inventor(s)01 / KLUGER, Dominique
Siemensstrasse 107
A-1210 Vienna / AT
02 / HAULER, Albin
Siemensstrasse 107
A-1210 Vienna / AT
03 / SCHMIDT, Carsten
Intervet Innovation GmbH
Zur Propstei
55270 Schwabenheim an der Selz / DE
04 / SCHROECKENFUCHS, David
Siemensstrase 107
A-1210 Vienna / AT
05 / WALDRON, Niki
556 Morris Avenue
Summit, New Jersey 07901 / US
 [2015/40]
Representative(s)Intervet International B.V.
Hertford Road
Hoddesdon, Hertfordshire EN11 9BU / GB
[2015/40]
Application number, filing date13792909.719.11.2013
[2015/40]
WO2013EP74127
Priority number, dateUS201261728379P20.11.2012         Original published format: US 201261728379 P
US201361791385P15.03.2013         Original published format: US 201361791385 P
[2015/40]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014079825
Date:30.05.2014
Language:EN
[2014/22]
Type: A1 Application with search report 
No.:EP2922526
Date:30.09.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 30.05.2014 takes the place of the publication of the European patent application.
[2015/40]
Type: B1 Patent specification 
No.:EP2922526
Date:27.10.2021
Language:EN
[2021/43]
Search report(s)International search report - published on:EP30.05.2014
ClassificationIPC:A61K9/20, A61K31/42, A61P33/10, A61P33/14, A61P43/00
[2021/25]
CPC:
A61K9/0056 (EP,KR,US); A61K9/00 (RU); A61K31/42 (EP,KR,US);
A61K31/4439 (RU); A61K47/10 (US); A61K9/2095 (EP);
A61P33/00 (EP,KR); A61P33/10 (EP); A61P33/14 (EP);
A61P43/00 (EP); B29C43/003 (US); B29K2071/02 (US);
B29K2105/0035 (US); B29L2031/753 (US) (-)
Former IPC [2021/22]A61K31/42, A61K9/00, A61P33/10, A61P33/14, A61P43/00
Former IPC [2015/40]A61K9/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/40]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:HERSTELLUNG VON PHARMAZEUTISCHEN SEMI-KUNSTSTOFF-DOSISEINHEITEN[2015/40]
English:MANUFACTURING OF SEMI-PLASTIC PHARMACEUTICAL DOSAGE UNITS[2015/40]
French:FABRICATION D'UNITÉS D'ADMINISTRATION PHARMACEUTIQUE SEMI PLASTIQUES[2015/40]
Entry into regional phase22.06.2015National basic fee paid 
22.06.2015Designation fee(s) paid 
22.06.2015Examination fee paid 
Examination procedure22.06.2015Examination requested  [2015/40]
30.12.2015Amendment by applicant (claims and/or description)
10.02.2017Despatch of a communication from the examining division (Time limit: M06)
15.08.2017Reply to a communication from the examining division
30.08.2018Despatch of a communication from the examining division (Time limit: M06)
20.09.2018Observations by third parties
03.04.2019Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
28.05.2019Reply to a communication from the examining division
07.01.2020Observations by third parties
23.10.2020Despatch of a communication from the examining division (Time limit: M04)
17.12.2020Observations by third parties
22.02.2021Reply to a communication from the examining division
02.06.2021Communication of intention to grant the patent
20.09.2021Fee for grant paid
20.09.2021Fee for publishing/printing paid
20.09.2021Receipt of the translation of the claim(s)
Divisional application(s)EP21197356.5  / EP3964198
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  10.02.2017
Opposition(s)Opponent(s)01  26.07.2022  29.07.2022  ADMISSIBLE
KRKA, d.d., Novo mesto
Smarjeska cesta 6
8501 Novo Mesto / SI
Opponent's representative
Hoefer & Partner Patentanwälte mbB
Pilgersheimer Straße 20
81543 München / DE
 [2022/36]
08.08.2022Invitation to proprietor to file observations on the notice of opposition
16.12.2022Reply of patent proprietor to notice(s) of opposition
05.11.2024Date of oral proceedings
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
28.05.2019Request for further processing filed
28.05.2019Full payment received (date of receipt of payment)
Request granted
13.06.2019Decision despatched
Fees paidRenewal fee
06.11.2015Renewal fee patent year 03
07.11.2016Renewal fee patent year 04
08.11.2017Renewal fee patent year 05
08.11.2018Renewal fee patent year 06
14.11.2019Renewal fee patent year 07
10.11.2020Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL27.10.2021
CY27.10.2021
EE27.10.2021
HR27.10.2021
LT27.10.2021
LV27.10.2021
MC27.10.2021
MK27.10.2021
RS27.10.2021
SM27.10.2021
LU19.11.2021
IS27.02.2022
[2024/22]
Former [2023/30]AL27.10.2021
CY27.10.2021
EE27.10.2021
HR27.10.2021
LT27.10.2021
LV27.10.2021
MC27.10.2021
RS27.10.2021
SM27.10.2021
LU19.11.2021
IS27.02.2022
Former [2022/49]AL27.10.2021
EE27.10.2021
HR27.10.2021
LT27.10.2021
LV27.10.2021
MC27.10.2021
RS27.10.2021
SM27.10.2021
LU19.11.2021
IS27.02.2022
Former [2022/34]EE27.10.2021
HR27.10.2021
LT27.10.2021
LV27.10.2021
MC27.10.2021
RS27.10.2021
SM27.10.2021
LU19.11.2021
IS27.02.2022
Former [2022/33]HR27.10.2021
LT27.10.2021
LV27.10.2021
MC27.10.2021
RS27.10.2021
SM27.10.2021
IS27.02.2022
Former [2022/24]HR27.10.2021
LT27.10.2021
LV27.10.2021
RS27.10.2021
IS27.02.2022
Former [2022/22]LT27.10.2021
RS27.10.2021
Former [2022/21]RS27.10.2021
Cited inInternational search[XY]WO2004014143  (AKZO NOBEL [NL], et al);
 [XY]US2007060494  (HALDAR RAMA [US], et al);
 [XY]WO2007130478  (NOVARTIS AG [CH], et al);
 [Y]WO2009002809  (DU PONT [US], et al);
 [Y]WO2009024541  (INTERVET INT BV [NL], et al);
 [XP]WO2013150052  (INTERVET INT BV [NL], et al)
otherWO2009024541
OppositionGB394489
 US4059378
 US4586888
 US4904495
 US5000973
 EP1163901
 US2003082283
 WO2004014143
 WO2007067582
 WO2007130478
 US2008075759
 WO2009024541
 WO2012120156
 WO2013150052
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.